ERAS items adopted | Conventional care |
---|---|
Preadmission information, education, and counseling (dedicated preoperative counseling about ERAS protocol) | Not applicable |
Preoperative optimization (increasing preoperative exercise and avoid smoking and drinking alcohol 1-month prior surgery) | None |
Preoperative fasting and carbohydrate loading (fluid up to 2 h and solid up to 6 h prior of induction of anesthesia, preoperative carbohydrate loading) | Preoperative fasting 12 h prior of induction of anesthesia |
Preoperative thromboprophylaxis with LMWH; extended prophylaxis for 28 days for colorectal cancer patients | Same protocol |
Avoid pre-anesthetic medication (midazolam) or, if necessary, administer short-acting intravenous drugs | Pre-anesthetic medication routinely used |
Antimicrobial prophylaxis (preoperative intravenous antibiotics) and skin preparation | Antibiotic prophylaxis prolonged for 48 h postoperatively |
Multimodal approach to PONV preoperatively (minimal preoperative fasting, carbohydrate loading), intraoperative (anesthetic PONV prevention), and postoperatively (add antiemetic that were not used for prophylaxis) | Treating PONV with antiemetics only once has already appeared |
Standard anesthetic protocol allowing rapid awakening | None |
Perioperative fluid management (balanced crystalloid, intraoperative fluids administration guided by flow measurements in open surgery, vasopressor in management of epidural-induced hypotension, early enteral administration of fluids) | Balanced crystalloid |
Preventing intraoperative hypothermia (intraoperative maintenance of normothermia with warming device and warmed intravenous fluid to keep temperature > 36 °C) | Use of warmed intravenous fluid |
Minimally invasive surgical access recommended (7/9 surgeon MIS trained) | Few surgeons (2/9) MIS trained |
Drainage of the peritoneal cavity and pelvis (routine drainage discouraged, early removal in POD 1/2 when no blood or purulent output) | Abdominal drainage routinely used, removed when output < 100 ml |
Nasogastric Intubation not inserted, unless gastric distension in presence of bowel occlusion | Nasogastric tube routinely used and removed when output < 200 ml/day |
Postoperative analgesia (FANS +/- Tap block) | PCA with morfine |
Urinary drainage (not routinely used, removed when possible after postoperative day 1/2) T4 patients with pelvic mass or with bladder involvement are considered high risk for urinary retention, therefore maintained urinary catheter at least until day 3 | Urinary catheter removal after postoperative day 4/5 or when patients were able to mobilize |
Postoperative glycemic control (use of stress reducing element of ERAS to minimize hyperglycemia, insulin treatment in ICU and ward setting when required) | Standard glycemic control |
Postoperative nutritional care (postoperative early enteral feeding and nutritional screening) | Enteral feeding resumed when bowel movement present and nasogastric tube output < 100 ml |
Early mobilization within first postoperative day. Patient’s counseling, dedicated nursing staff, and physiotherapists to early mobilization | Mobilization after removal of Foley catheter. Never before postoperative day 3 |